ProLogium signed a definitive SPAC merger on May 27, 2026, with Translational Sciences Acquisition Corporation to raise approximately $800 million in gross proceeds. The capital targets a 25 GWh annual capacity solid-state battery plant in Dunkirk, France, scheduled to break ground in Q4 2026. The facility represents ProLogium's first manufacturing footprint outside Taiwan and its first attempt to scale beyond pilot production volumes.
The company has operated for fourteen years without shipping commercial-scale product. ProLogium claims 738 patents filed across solid electrolyte chemistry and lithium-ceramic interfaces, but its only disclosed customer contracts remain non-binding memoranda of understanding with Mercedes-Benz and an unnamed European OEM. The SPAC structure allows ProLogium to avoid traditional IPO scrutiny on revenue forecasts — the investor presentation projects $2.1 billion in 2029 revenue with zero disclosed 2026 sales. The Translational Sciences SPAC raised $230 million in its January 2025 IPO at $10.00 per unit; redemption rates and PIPE commitments remain undisclosed in the preliminary S-4 filing.
This follows the QuantumScape template: go public on solid-state promise, build the factory with public capital, defer production timelines when physics resists projection. QuantumScape announced its deSPAC in September 2020 at a $3.3 billion valuation, peaked at $47.7 billion market cap by December 2020, and now trades at $1.1 billion after pushing commercial delivery from 2024 to 2028. The difference: ProLogium already produces small-volume pouch cells in Taoyuan at 1.8 GWh annual capacity, shipping samples to OEMs for validation testing. The question is whether sample-scale chemistry survives the thermal and mechanical stresses of gigawatt manufacturing.
Solid-state batteries replace liquid electrolyte with ceramic or polymer solid electrolyte, theoretically enabling 400+ Wh/kg energy density versus 250-280 Wh/kg for NMC lithium-ion. The engineering challenge is interface stability: lithium metal anodes dendrite through ceramic grain boundaries during charge cycles, causing internal shorts. ProLogium's disclosed solution uses a hybrid architecture with oxide-ceramic separator and lithium-metal-composite anode, but the company has not published peer-reviewed dendrite mitigation data. Toyota, Samsung SDI, and Solid Power are all targeting 2027-2028 for solid-state pilot production; none have committed to gigawatt-scale capex.
Allocators should watch ProLogium's Q3 2026 S-4 effective date for redemption rates — high redemptions signal institutional skepticism on the timeline. The Dunkirk plant economics depend on securing €400 million in French government subsidies under the European Battery Alliance, with final terms expected by August 2026. Mercedes-Benz is contractually required to clarify binding volume commitments by September 2026 or the MoU expires. If ProLogium cannot convert at least one MoU into a fixed-price contract by year-end 2026, the gigawatt buildout becomes a $1.2 billion bet on phantom demand.
The France site selection is political arbitrage. Dunkirk offers Atlantic port access, proximity to Stellantis and Renault assembly plants, and eligibility for EU carbon-border-adjustment credits when exporting to the UK. The subsidy package likely includes land at symbolic lease rates and exemptions from France's 25% corporate tax for ten years. ProLogium will book the subsidy as deferred revenue, flattering gross margins in 2028-2029 before actual cell sales prove unit economics. The SPAC proceeds close in Q4 2026, construction begins three months later, and equipment commissioning is projected for Q2 2028 — an eighteen-month timeline that assumes zero permitting delays and flawless solid-electrolyte coating scale-up.